Assessment of Point-of-Care Diagnostics for G6PD Deficiency in Malaria Endemic Rural Eastern Indonesia

PLoS Neglected Tropical Diseases

Volumn 10, Issue 2, 2016, Pages

  Satyagraha, Ari W ^a   Sadhewa, Arkasha ^a   Elvira, Rosalie ^a   Elyazar, Iqbal ^b   Feriandika, Denny ^a   Antonjaya, Ungke ^b   Oyong, Damian ^b   Subekti, Decy ^b   Rozi, Ismail E ^a   Domingo, Gonzalo J ^c   Harahap, Alida R ^a   Baird, J Kevin ^b,d  

^a EIJKMAN INSTITUTE FOR MOLECULAR BIOLOGY   (Indonesia)

^b OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^c PATH   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PRIMAQUINE;

ADULT; ANEMIA; ARTICLE; BLOOD ANALYSIS; CHILD; DNA DETERMINATION; ERYTHROCYTE DISORDER; FEMALE; FLUORESCENT SPOT TEST; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHY; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HUMAN; INDONESIA; MALARIA; MALE; NORMAL HUMAN; OUTCOME ASSESSMENT; POINT OF CARE TESTING; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PUBLIC HEALTH; QUALITATIVE ANALYSIS; QUANTITATIVE SPECTROPHOTOMETRY; RURAL AREA; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY; THALASSEMIA; ADOLESCENT; COMPLICATION; DIAGNOSTIC TEST; ENZYMOLOGY; EVALUATION STUDY; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; POINT OF CARE SYSTEM; PROCEDURES; RURAL HEALTH; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; DIAGNOSTIC TESTS, ROUTINE; FEMALE; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HUMANS; INDONESIA; MALARIA; MALE; POINT-OF-CARE SYSTEMS; RURAL HEALTH; YOUNG ADULT;

EID: 84959291052     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0004457     Document Type: Article

References (40)

1. Cappellini MD, Fiorelli G, Glucose-6-phosphate dehydrogenase deficiency. Lancet2008; 371: 64–74. doi: 10.1016/S0140-6736(08)60073-218177777
2. Youngster I, Arcavi L, Schechmaster R, Akayzen Y, Popliski H, Shimonov J, Beig S, Berkovitch M, Medications and glucose-6-phosphate dehydrogenase deficiency: and evidence-based review. Drug Saf2010; 33: 713–26. doi: 10.2165/11536520-000000000-0000020701405
3. Howes RE, Battle KE, Satyagraha AW, Baird JK, Hay SI, G6PD deficiency: global distribution, genetic variants and primaquine therapy. Adv Parasitol2013; 81: 133–201. doi: 10.1016/B978-0-12-407826-0.00004-723384623
4. Baird JK, Hoffman SL, Primaquine therapy for malaria. Clin Infect Dis2004; 37: 1659–67.
5. Alving AS, Carson PE, Flanagan CL, Ickes CE, Enzymatic deficiency in primaquine-sensitive erythrocytes. Science1956; 124: 484–5.
6. Dern R, Beutler E, Alving AS, The hemolytic effect of primaquine. II. The natural course of hemolytic anemia and mechanism of its self-limited character. J Lab Clin Med1954; 44: 171–6. 13184224
7. Alving AS, Johnson CF, Tarlov AR, Brewer GJ, Kellermeyer RW, Carson PE, Mitigation of the haemolytic effect of primaquine and enhancement of its action against exoerythrocytic forms of the Chesson strain of Plasmodium vivax by intermittent regimens of drug administration. Bull WHO1960; 22: 621–31. 13793053
8. Pannacciulli I, Tizianello A, Ajmar F, Salvidio E, The course of experimentally induced hemolytic anemia in a primaquine-sensitive Caucasian: a case study. Blood1965; 25: 92–5. 14255977
9. George JN, Sears DA, McCurdy PR, Conrad ME, Primaquine sensitivity in Caucasians: hemolytic reactions induced by primaquine in G6PD deficient subjects. J Lab Clin Med1967; 70: 80–93. 6027097
10. Bonsignore A, Foraini G, Fantoni A, Leoncini G, Segni P, Relationship between age and enzymatic activities in human erythrocytes from normal and fava bean-sensitive subject. J Clin Invest1964; 43: 834. 14169512
11. Piomelli S, Corash LM, Davenport DD, Miraglia J, Amorosi EL, In vivo liability of glucose-6-phosphate dehydrogenase in GdA- and GdMediterranean deficiency. J Clin Invest1968; 47: 940–8. 5641629
12. Salvidio E, Pannacciulli Tizianello A, Ajmar F, Nature of hemolytic crises and the fate of G6PD deficient, drug-damaged erythrocytes in Sardinians. New Engl J Med1967; 276: 1339–44. 6024564
13. Ebisawa I, Muto T, Malaria in Laos. Primaquine sensitivity of the Laotians and Japanese. Jpn J Exp Med1972; 42: 415–7. 4538385
14. Chopra SA, Hemolytic crisis in a Zanzibari Arab girl with G6PD deficiency and sickle cell trait. East Afr Med J1968; 45: 726–7. 5721119
15. Ziai M, Amirhakimi GH, Reinhold JG, Tabatabee M, Gettner MS, Bowman JE, Malaria prophylaxis and treatment in G6PD deficiency: an observation on the toxicity of chloroquine and primaquine. Clin Pediatr1967; 6: 242–3.
16. Abeyarantne KP, Halpe NL, Sensitivity to primaquine in Ceylonese children due to deficiency of erythrocytic glucose-6-phosphate dehydrogenase deficiency. Ceylon Med J1968; 13: 134–8. 5721557
17. Lacerda MV, Fragoso SC, Alecrim MG, Alexandre MA, Magalhaes BM, et al. Postmortem characterization of patients with a clinical diagnosis of Plasmodium vivax: to what extent does this parasite kill?Clin Infect Dis2012; 55: e67–74. 22772803
18. Clyde DF, Clinical problems associated with the use of primaquine as a tissue schizontocidal and gametocytocidal drug. Bull WHO1981; 59: 391–5. 6976846
19. Howes RE, Piel FB, Patil AP, Nyangiri OA, Gething PW, et al. G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical-based map. PLoS Med2012; 9: e1001339. doi: 10.1371/journal.pmed.100133923152723
20. Anstey NM, Douglas NM, Poespoprodjo JR, Price RN, Plasmodium vivax: clinical spectrum, risk factors and pathogenesis. Adv Parasitol2012; 80: 151–201. doi: 10.1016/B978-0-12-397900-1.00003-723199488
21. Baird JK, Evidence and implications of mortality associated with acute Plasmodium vivax malaria. Clin Microbiol Rev2013; 26: 36–57. doi: 10.1128/CMR.00074-1223297258
22. Naing C, Whittaker MA, Nyunt Wai V, Mak JW, Is Plasmodium vivax a severe malaria?: a systematic review and meta-analysis. PLoS Negl Trop Dis2014; 8: e3071. doi: 10.1371/journal.pntd.000307125121491
23. World Health OrganizationGlobal Technical Strategy for Malaria 2016–2030. 2015. Geneva. 35pp.
24. World Health Organization2015. Control and Elimination of Plasmodium vivax Malaria. A Technical Brief. Geneva. 64pp.
25. Beutler E, A series of new screening procedures for pyruvate kinase deficiency, glucose-6-phosphate dehydrogenase deficiency, and glutathione reductase deficiency. Blood1966; 28: 553–62. 5923607
26. Domingo GJ, Satyagraha AW, Anvikar A, Baird JK, Bancone G, et al. G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests. Malaria J2013; 12: 391.
27. von Seidlein L, Auburn S, Espino F, Shanks D, Cheng Q, et al. Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report. Malaria J2013; 12: 112.
28. World Health Organization. 2015. Point-of-care G6PD testing to support safe use of primaquine for the treatment of vivax malaria. WHO Evidence Review Group meeting report 8–9 October 2014, WHO/UNAIDS Building, Geneva, Switzerland (http://www.who.int/malaria/mpac/mpac-march2015-erg-g6pd.pdf accessed 26 October 2015).
29. Satyagraha AW, Sadhewa A, Baramuli V, Elvira R, Ridenour C, et al. G6PD deficiency at Sumba in eastern Indonesia is prevalent, diverse and severe: implications for primaquine therapy against relapsing vivax malaria. PLOS Negl Trop Dis2015; 9: e0003602. doi: 10.1371/journal.pntd.000360225746733
30. Baird JK, Dewi M, Subekti D, Elyazar I, Satyagraha AW, Non-inferiority of glucose-6-phosphate dehydrogenase deficiency diagnosis by a point-of-care rapid test vs the laboratory fluorescent spot test demonstrated by copper inhibition in normal human red blood cells. Transl Res2015; 165: 677–688. doi: 10.1016/j.trsl.2014.09.00925312015
31. Saunders MA, Hammer MF, Nachman MW, Nucleotide variability at G6PD and the signature of malaria selection in humans. Genetics2002; 162: 1849–61. 12524354
32. Liu YT, Old JM, Miles K, Fisher CA, Weatherall DJ, Clegg JB, Rapid detection of a-thalassaemia deletions and a-globin gene triplication by multiplex polymerase chain reactions. Brit J Haematol2000;108:295–299.
33. Setianingsih I, Harahap A, Nainggolan IM, Alpha thalassemia in Indonesia: phenotypes and molecular defects. Adv Exp Med Biol2003; 531: 47–56. 12916780
34. Ainoon O, Alawiyah A, Yu YH, Cheong SK, Hamidah NH, Boo NY, Zaleha M, Semiquantitative screening test for G6PD deficiency detects severe deficiency but misses a substantial proportion of partially-deficient females. Southeast Asian J Trop Med Public Health2003; 34: 405–14. 12971572
35. Baird JK, Satyagraha AW, Bancone G, Hommel M, Kremsner PG, Glucose-6-phosphate dehydrogenase deficiency and primaquine hemolytic toxicity. In: Encyclopedia of Malaria Springer. 2014.
36. Baird JK, Point-of-care G6PD diagnostics for Plasmodium vivax malaria is clinical and public health urgency. BMC Med, in press.
37. Roca-Feltrer A, Khim N, Kim S, Chy S, Canier L, et al. Field trial evaluation of the performances of point-of-care tests for screening G6PD deficiency in Cambodia. PLoS One2014; 9: e116143. doi: 10.1371/journal.pone.011614325541721
38. Adu-Gyasi D, Asante KP, Newton S, Dosoo D, Amoako S, et al. Evaluation of the diagnostic accuracy of the CareStart G6PD deficiency rapid diagnostic test (RDT) in a malaria endemic area in Ghana, Africa. PLoS One2015; 10: e0125796. doi: 10.1371/journal.pone.012579625885097
39. von Fricken ME, Weppelmann TA, Eaton WT, Masse R, Beau de Rochars MV, Okech BA, Performance of the CareStart glucose-6-phosphate dehydrogenase (G6PD) rapid diagnostic test in Gressier, Haiti. Am J Trop Med Hyg2014; 91: 77–80. doi: 10.4269/ajtmh.14-010024778197
40. Bancone G, Chu CS, Chowwiwat N, Somsakchaicharoen R, Wilaisrisak P, et al. Suitability of capillary blood for quantitative assessment of G6PD activity and performances of G6PD point-of-care tests. Am J Trop Med Hyg2015; 92: 818–24. doi: 10.4269/ajtmh.14-069625646252